[Biopathology of idiopathic pulmonary arterial hypertension].
In recent years, several important outcomes have allowed increasing our understanding in the biopathology of idiopathic pulmonary arterial hypertension. Although the triggering event remains unknown, some of the adjacent mechanisms of disease had been identified.
openaire +1 more source
Phenotyping vasodilator responsiveness in idiopathic pulmonary arterial hypertension: any role for the cardiopulmonary exercise test? [PDF]
Sivasubramaniam G +6 more
europepmc +1 more source
MiR-122-5p as a potential regulator of pulmonary vascular wall cell in idiopathic pulmonary arterial hypertension. [PDF]
Zhao H +13 more
europepmc +1 more source
Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension. [PDF]
Zhang Y +7 more
europepmc +1 more source
Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report. [PDF]
Alexandre A +7 more
europepmc +1 more source
Understanding longitudinal bi-ventricular structural and functional changes in a Pulmonary Hypertension Sugen-Hypoxia rat model by Cardiac Magnetic Resonance Imaging [PDF]
Buist, Hanna +14 more
core +2 more sources
Gene and metabolite changes triggered by downregulation of JUNB and ZNF281 in idiopathic pulmonary arterial hypertension: potential mechanisms revealed by multi-omics study. [PDF]
Zong Y +6 more
europepmc +1 more source
Ten-year survival, trends and risk stratification of newly diagnosed idiopathic pulmonary arterial hypertension in China: insights from a national multicenter prospective registry. [PDF]
Wu Y +14 more
europepmc +1 more source
Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. [PDF]
Friedman SH +8 more
europepmc +1 more source
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension. [PDF]
Natalia G +7 more
europepmc +1 more source

